[{"Assets_0_Q3_USD":"470454000.0","CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.37","EarningsPerShareBasic_3_Q3_USD":"-1.53","EarningsPerShareDiluted_1_Q3_USD":"-0.37","EarningsPerShareDiluted_3_Q3_USD":"-1.53","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"15507000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-4447000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-18467000.0","NetIncomeLoss_1_Q3_USD":"-4447000.0","NetIncomeLoss_3_Q3_USD":"-18467000.0","OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q3_USD":"52061000.0","RevenuesConverted_3_Q3_USD":"155207000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"191403000.0","Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"12107000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"12066000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"12107000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"12066000.0","filed":"20211101","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"ANI PHARMACEUTICALS INC","period":"20210930","qtrs":"3","uom":"USD"}]